Annual Cash & Cash Equivalents
$55.90 M
-$84.61 M-60.22%
December 31, 2023
Summary
- As of February 7, 2025, RCKT annual cash & cash equivalents is $55.90 million, with the most recent change of -$84.61 million (-60.22%) on December 31, 2023.
- During the last 3 years, RCKT annual cash & cash equivalents has fallen by -$241.19 million (-81.18%).
- RCKT annual cash & cash equivalents is now -81.18% below its all-time high of $297.10 million, reached on December 31, 2020.
Performance
RCKT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$65.60 M
+$26.99 M+69.91%
September 30, 2024
Summary
- As of February 7, 2025, RCKT quarterly cash and cash equivalents is $65.60 million, with the most recent change of +$26.99 million (+69.91%) on September 30, 2024.
- Over the past year, RCKT quarterly cash and cash equivalents has dropped by -$160.06 million (-70.93%).
- RCKT quarterly cash and cash equivalents is now -77.92% below its all-time high of $297.10 million, reached on December 31, 2020.
Performance
RCKT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RCKT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.2% | -70.9% |
| 3 y3 years | -81.2% | -70.9% |
| 5 y5 years | -49.8% | -70.9% |
RCKT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.0% | at low | -71.8% | +86.0% |
| 5 y | 5-year | -81.2% | at low | -77.9% | +86.0% |
| alltime | all time | -81.2% | +3974.6% | -77.9% | +1713.1% |
Rocket Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $65.60 M(+69.9%) |
| Jun 2024 | - | $38.61 M(+9.4%) |
| Mar 2024 | - | $35.28 M(-36.9%) |
| Dec 2023 | $55.90 M(-60.2%) | $55.90 M(-75.2%) |
| Sep 2023 | - | $225.66 M(+400.6%) |
| Jun 2023 | - | $45.08 M(-30.2%) |
| Mar 2023 | - | $64.58 M(-54.0%) |
| Dec 2022 | $140.52 M(-39.6%) | $140.52 M(-28.6%) |
| Sep 2022 | - | $196.67 M(+4.9%) |
| Jun 2022 | - | $187.55 M(+43.7%) |
| Mar 2022 | - | $130.55 M(-43.9%) |
| Dec 2021 | $232.69 M(-21.7%) | $232.69 M(-5.3%) |
| Sep 2021 | - | $245.64 M(-7.2%) |
| Jun 2021 | - | $264.61 M(+4.8%) |
| Mar 2021 | - | $252.54 M(-15.0%) |
| Dec 2020 | $297.10 M(+60.3%) | $297.10 M(+261.3%) |
| Sep 2020 | - | $82.23 M(-49.6%) |
| Jun 2020 | - | $163.20 M(-14.3%) |
| Mar 2020 | - | $190.52 M(+2.8%) |
| Dec 2019 | $185.38 M | $185.38 M(+107.8%) |
| Sep 2019 | - | $89.19 M(+37.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $64.83 M(-47.9%) |
| Mar 2019 | - | $124.46 M(+11.8%) |
| Dec 2018 | $111.36 M(+41.5%) | $111.36 M(+192.5%) |
| Sep 2018 | - | $38.08 M(-27.5%) |
| Jun 2018 | - | $52.55 M(-69.3%) |
| Mar 2018 | - | $171.14 M(+117.4%) |
| Dec 2017 | $78.72 M(+164.2%) | $78.72 M(+60.2%) |
| Sep 2017 | - | $49.15 M(+78.0%) |
| Jun 2017 | - | $27.61 M(+9.2%) |
| Mar 2017 | - | $25.27 M(-15.2%) |
| Dec 2016 | $29.80 M(-62.8%) | $29.80 M(-64.1%) |
| Sep 2016 | - | $83.00 M(+115.5%) |
| Jun 2016 | - | $38.52 M(-34.4%) |
| Mar 2016 | - | $58.71 M(-26.7%) |
| Dec 2015 | $80.04 M(+2112.3%) | $80.04 M(-10.3%) |
| Sep 2015 | - | $89.25 M(+82.1%) |
| Jun 2015 | - | $49.01 M(-7.8%) |
| Mar 2015 | - | $53.14 M(+1368.7%) |
| Dec 2014 | $3.62 M(-71.7%) | $3.62 M(-50.8%) |
| Sep 2014 | - | $7.36 M(-42.5%) |
| Dec 2013 | $12.79 M(+832.4%) | $12.79 M |
| Dec 2012 | $1.37 M | - |
FAQ
- What is Rocket Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Rocket Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Rocket Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of RCKT is $55.90 M
What is the all time high annual cash & cash equivalents for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual cash & cash equivalents is $297.10 M
What is Rocket Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, RCKT annual cash & cash equivalents has changed by -$84.61 M (-60.22%)
What is Rocket Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RCKT is $65.60 M
What is the all time high quarterly cash and cash equivalents for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly cash and cash equivalents is $297.10 M
What is Rocket Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, RCKT quarterly cash and cash equivalents has changed by -$160.06 M (-70.93%)